West Family Investments’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,655
Closed -$226K 294
2025
Q4
$226K Hold
2,655
0.05% 318
2025
Q3
$206K Hold
2,655
0.05% 348
2025
Q2
$208K Buy
+2,655
New +$198K 0.05% 334
2022
Q3
Sell
-2,922
Closed -$278K 229
2022
Q2
$278K Buy
2,922
+567
+24% +$58.7K 0.11% 175
2022
Q1
$277K Sell
2,355
-55
-2% -$6.17K 0.08% 203
2021
Q4
$312K Hold
2,410
0.09% 193
2021
Q3
$273K Buy
2,410
+132
+6% +$15.1K 0.07% 228
2021
Q2
$236K Buy
+2,278
New +$215K 0.06% 287

Other funds holding EW

West Family Investments's EW Position: Q1 2026 in Review

West Family Investments sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 2,655 shares — an estimated $226K sold.

West Family Investments first reported a position in EW in Q2 2021 and held it in 8 quarters. The position peaked at $312K in Q4 2021. 1,288 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • West Family Investments reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
  • West Family Investments sold 2,655 Edwards Lifesciences shares in Q1 2026, an estimated $226K.
  • West Family Investments first reported a position in Edwards Lifesciences in Q2 2021 and held it in 8 quarters.
  • West Family Investments's Edwards Lifesciences position peaked at $312K in Q4 2021.
  • 1,288 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on West Family Investments's 13F filing for Q1 2026, filed 7 May 2026.